These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17219009)

  • 1. Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients.
    Assis AM; Costa FF; Arruda VR; Annichino-Bizzacchi JM; Bertuzzo CS
    J Hum Genet; 2007; 52(3):237-243. PubMed ID: 17219009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.
    Letteboer TG; Zewald RA; Kamping EJ; de Haas G; Mager JJ; Snijder RJ; Lindhout D; Hennekam FA; Westermann CJ; Ploos van Amstel JK
    Hum Genet; 2005 Jan; 116(1-2):8-16. PubMed ID: 15517393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
    Bossler AD; Richards J; George C; Godmilow L; Ganguly A
    Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.
    Lenato GM; Lastella P; Di Giacomo MC; Resta N; Suppressa P; Pasculli G; Sabbà C; Guanti G
    Hum Mutat; 2006 Feb; 27(2):213-4. PubMed ID: 16429404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in ALK-1 causes hereditary hemorrhagic telangiectasia type 2.
    Yan ZM; Fan ZP; Du J; Hua H; Xu YY; Wang SL
    J Dent Res; 2006 Aug; 85(8):705-10. PubMed ID: 16861286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia.
    Alaa El Din F; Patri S; Thoreau V; Rodriguez-Ballesteros M; Hamade E; Bailly S; Gilbert-Dussardier B; Abou Merhi R; Kitzis A
    PLoS One; 2015; 10(7):e0132111. PubMed ID: 26176610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.
    Schulte C; Geisthoff U; Lux A; Kupka S; Zenner HP; Blin N; Pfister M
    Hum Mutat; 2005 Jun; 25(6):595. PubMed ID: 15880681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.
    Fontalba A; Fernandez-L A; García-Alegria E; Albiñana V; Garrido-Martin EM; Blanco FJ; Zarrabeitia R; Perez-Molino A; Bernabeu-Herrero ME; Ojeda ML; Fernandez-Luna JL; Bernabeu C; Botella LM
    BMC Med Genet; 2008 Aug; 9():75. PubMed ID: 18673552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary hemorrhagic telangiectasia resulted from a nonsense mutation Arg479 Stop in the ALK-1 gene].
    Xie BS; Xie S; Chen P; Zhu MY; Zheng JY; Wang XF; Fu QH; Zhou RF; Wang WB; Wu WM; Ding QL; Wang HL; Hu LM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):536-9. PubMed ID: 15569532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
    J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.
    Lesca G; Plauchu H; Coulet F; Lefebvre S; Plessis G; Odent S; Rivière S; Leheup B; Goizet C; Carette MF; Cordier JF; Pinson S; Soubrier F; Calender A; Giraud S;
    Hum Mutat; 2004 Apr; 23(4):289-99. PubMed ID: 15024723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
    Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
    Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
    Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
    Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.